David Gius, MD,PHD

Tao R.; Coleman M.C.; Pennington J.D.; Ozden O.; Park S.H.; Jiang H.; Kim H.S.; Flynn C.R.; Hill S.; McDonald W.H.; Olivier A.K.; Spitz D.R.; Gius D. 12-22-2010. Sirt3-Mediated Deacetylation of Evolutionarily Conserved Lysine 122 Regulates MnSOD Activity in Resp Molecular Cell, 40 6, 893-904

Bisht K.S.; Bradbury C.M.; Mattson D.; Kaushal A.; Sowers A.; Markovina S.; Ortiz K.L.; Sieck L.K.; Isaacs J.S.; Brechbiel M.W.; Mitchell J.B.; Neckers L.M.; Gius D. 12-15-2003. Geldanamycin and 17-Allylamino-17-demethoxygeldanamycin Potentiate the in Vitro and in Vivo Radiatio Cancer Research, 63 24, 8984-8995

Goswami P.C.; Sheren J.; Albee L.D.; Parsian A.; Sim J.E.; Ridnour L.A.; Higashikubo R.; Gius D.; Hunt C.R.; Spitz D.R. 12-08-2000. Cell cycle-coupled variation in topoisomerase II? mRNA is regulated by the 3?-untranslated region: P Journal of Biological Chemistry, 275 49, 38384-38392

Zhu Y.; Zou X.; Dean A.E.; Brien J.O.; Gao Y.; Tran E.L.; Park S.H.; Liu G.; Kieffer M.B.; Jiang H.; Stauffer M.E.; Hart R.; Quan S.; Satchell K.J.F.; Horikoshi N.; Bonini M.; Gius D. 12-01-2019. Lysine 68 acetylation directs MnSOD as a tetrameric detoxification complex versus a monomeric tumor Nature Communications, 10 1,

Lantier L.; Williams A.S.; Hughey C.C.; Bracy D.P.; James F.D.; Ansari M.A.; Gius D.; Wasserman D.H. 12-01-2018. SIRT2 knockout exacerbates insulin resistance in high fat-fed mice Plos One, 13 12,

Quan S.; Principe D.R.; Dean A.E.; Park S.H.; Grippo P.J.; Gius D.; Horikoshi N. 12-01-2018. Loss of Sirt2 increases and prolongs a caerulein-induced pancreatitis permissive phenotype and induc Scientific Reports, 8 1,

Rader J.S.; Malone J.P.; Gross J.; Gilmore P.; Brooks R.A.; Nguyen L.; Crimmins D.L.; Feng S.; Wright J.D.; Taylor N.; Zighelboim I.; Funk M.C.; Huettner P.C.; Ledenson J.H.; Gius D.; Townsend R.R. 12-01-2008. A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to ident Proteomics Clinical Applications, 2 12, 1658-1669

Sharp H.; Morris J.C.; Van Waes C.; Gius D.; Cooley-Zgela T.; Singh A.K. 12-01-2008. High incidence of oral dysesthesias on a trial of gefitinib, paclitaxel, and concurrent external bea American Journal of Clinical Oncology Cancer Clinical Trials, 31 6, 557-560

Van Waes C.; Chang A.A.; Lebowitz P.F.; Druzgal C.H.; Chen Z.; Elsayed Y.A.; Sunwoo J.B.; Rudy S.F.; Morris J.C.; Mitchell J.B.; Camphausen K.; Gius D.; Adams J.; Sausville E.A.; Conley B.A. 12-01-2005. Inhibition of nuclear factor-?B and target genes during combined therapy with proteasome inhibitor b International Journal of Radiation Oncology Biology Physics, 63 5, 1400-1412

Bjornsson H.T.; Cui H.; Gius D.; Fallin M.D.; Feinberg A.P. 12-01-2004. The new field of epigenomics: Implications for cancer and other common disease research Cold Spring Harbor Symposia on Quantitative Biology, 69 , 447-456

Roti Roti J.; Gius D.; VanderWaal R.; Xu M. 12-01-2000. Rearrangement of chromatin domains in cancer and development Journal of Cellular Biochemistry, 80 SUPPL. 35, 54-60

Wei S.; Botero A.; Hirota K.; Bradbury C.; Markovina S.; Laszlo A.; Spitz D.; Goswami P.; Yodoi J.; Gius D. 12-01-2000. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protei Cancer Research, 60 23, 6688-6695

Xiao C.; Kim H.S.; Lahusen T.; Wang R.H.; Xu X.; Gavrilova O.; Jou W.; Gius D.; Deng C.X. 11-19-2010. SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated gluco Journal of Biological Chemistry, 285 47, 36776-36784

Leung J.W.; Gius D. 11-17-2025. GSK3? guides chromosomal repair pathway selection to support BRCA1-independent PARP inhibitor sensit Journal of Clinical Investigation, 135 22, 1-3

Stoyanovsky D.A.; Tyurina Y.Y.; Tyurin V.A.; Anand D.; Mandavia D.N.; Gius D.; Ivanova J.; Pitt B.; Billiar T.R.; Kagan V.E. 11-16-2005. Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitroso Journal of the American Chemical Society, 127 45, 15815-15823

Annunziata C.; Kleinberg L.; Davidson B.; Berner A.; Gius D.; Tchabo N.; Steinberg S.; Kohn E. 11-15-2007. BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian Clinical Cancer Research, 13 22, 6585-6592

Gius D.; Coleman C.N. 11-06-2002. Treatment of nasopharyngeal cancer: Raising the "Barr" Journal of the National Cancer Institute, 94 21, 1594-1595

Traver G.; Mont S.; Gius D.; Lawson W.E.; Ding G.X.; Sekhar K.R.; Freeman M.L. 11-01-2017. Loss of Nrf2 promotes alveolar type 2 cell loss in irradiated, fibrotic lung Free Radical Biology and Medicine, 112 , 578-586

Vidimar V.; Gius D.; Chakravarti D.; Bulun S.E.; Wei J.J.; Kim J.J. 11-01-2016. Dysfunctional MnSOD leads to redox dysregulation and activation of prosurvival AKT signaling in uter Science Advances, 2 11,

Zhu Y.; Yan Y.; Gius D.; Vassilopoulos A. 11-01-2013. Metabolic regulation of Sirtuins upon fasting and the implication for cancer Current Opinion in Oncology, 25 6, 630-636

Nguyen P.; Bar-Sela G.; Sun L.; Bisht K.S.; Cui H.; Kohn E.; Feinberg A.P.; Gius D. 11-01-2008. BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4 histone dimethylation and gene expre Molecular and Cellular Biology, 28 21, 6720-6729

Fitzpatrick M.A.; Funk M.C.; Gius D.; Huettner P.C.; Zhang Z.; Bidder M.; Ma D.; Powell M.A.; Rader J.S. 11-01-2006. Identification of chromosomal alterations important in the development of cervical intraepithelial n Gynecologic Oncology, 103 2, 458-462

Bisht K.; Bradbury C.; Zoberi I.; Curry H.; Kaushal A.; Roti Roti J.; Gius D. 11-01-2003. Inhibition of cyclooxygenase-2 with NS-398 and the prevention of radiation-induced transformation, m International Journal of Radiation Biology, 79 11, 879-888

Gius D.; Bradbury C.M.; Sun L.; Awwad R.T.; Huang L.; Smart D.D.K.; Bisht K.S.; Ho A.S.; Nguyen P. 10-26-2005. The epigenome as a molecular marker and target: Implications for cancer Cancer, 104 9, 1789-1793

Horn L.; Eisenberg R.; Gius D.; Kimmelshue K.; Massion P.; Putnam J.; Robinson C.; Carbone D. 10-22-2013. Cancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer Abeloff S Clinical Oncology Fifth Edition, , 1143-1192

Markovina S.; Wei S.J.; Rene L.M.; Zoberi I.; Horikoshi N.; Bradbury C.M.; Gius D. 10-15-2001. Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-?B activatio Cancer Research, 61 20, 7689-7696

Prasanna P.G.; Citrin D.E.; Hildesheim J.; Ahmed M.M.; Venkatachalam S.; Riscuta G.; Xi D.; Zheng G.; Deursen J.v.; Goronzy J.; Kron S.J.; Anscher M.S.; Sharpless N.E.; Campisi J.; Brown S.L.; Niedernhofer L.J.; O'loghlen A.; Georgakilas A.G.; Paris F.; Gius D.; Gewirtz D.A.; Schmitt C.A.; Abazeed M.E.; Kirkland J.L.; Richmond A.; Romesser P.B.; Lowe S.W.; Gil J.; Mendonca M.S.; Burma S.; Zhou D.; Coleman C.N. 10-01-2021. Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy Journal of the National Cancer Institute, 113 10, 1285-1298

Bao J.; Scott I.; Lu Z.; Pang L.; Dimond C.; Gius D.; Sack M. 10-01-2010. SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity Free Radical Biology and Medicine, 49 7, 1230-1237

Dewhirst M.W.; Sneed P.K.; Karimpour S.; Gius D. 10-01-2003. Those in gene therapy should pay closer attention to lessons from hyperthermia [5] (multiple letter) International Journal of Radiation Oncology Biology Physics, 57 2, 597-599

Ezhevsky S.A.; Nagahara H.; Vocero-Akbani A.M.; Gius D.R.; Wei M.C.; Dowdy S.F. 09-30-1997. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in act Proceedings of the National Academy of Sciences of the United States of America, 94 20, 10699-10704

Maity S.; Venkatesan M.; Chidambaram A.; Uthayabalan S.; Faat Lai L.T.; Clark N.D.; Lakkureddi A.; Ramachandran K.; Bentz K.; Ramalingam R.; Sen S.; Akram M.; Weintraub S.T.; Singh B.B.; Gius D.; Baur J.A.; Theiss A.L.; Caplan J.; Matthies D.; Stathopulos P.B.; Madesh M. 09-22-2026. Prohibitin controls MRS2-Mediated mitochondrial Mg2+ uptake to Shape bioenergetics Cell Reports, 45 9,

Smart D.D.K.; Ortiz K.L.; Mattson D.; Bradbury C.M.; Bisht K.S.; Sieck L.K.; Brechbiel M.W.; Gius D. 09-15-2004. Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative st Cancer Research, 64 18, 6716-6724

Jacobs K.M.; Pennington J.D.; Bisht K.S.; Aykin-Burns N.; Kim H.S.; Mishra M.; Sun L.; Nguyen P.; Ahn B.H.; Leclerc J.; Deng C.X.; Spitz D.R.; Gius D. 09-05-2008. SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a depe International Journal of Biological Sciences, 4 5, 291-299

Kibria G.; Ramos E.K.; Wan Y.; Gius D.R.; Liu H. 09-04-2018. Exosomes as a Drug Delivery System in Cancer Therapy: Potential and Challenges Molecular Pharmaceutics, 15 9, 3625-3633

Lantier L.; Williams A.S.; Williams I.M.; Yang K.K.; Bracy D.P.; Goelzer M.; James F.D.; Gius D.; Wasserman D.H. 09-01-2015. SIRT3 is crucial for maintaining skeletal muscle insulin action and protects against severe insulin Diabetes, 64 9, 3081-3092

Liu R.; Fan M.; Candas D.; Qin L.; Zhang X.; Eldridge A.; Zou J.X.; Zhang T.; Juma S.; Jin C.; Li R.F.; Perks J.; Sun L.Q.; Vaughan A.T.M.; Hai C.X.; Gius D.R.; Li J.J. 09-01-2015. CDK1-mediated SIRT3 activation enhances mitochondrial function and tumor radioresistance Molecular Cancer Therapeutics, 14 9, 2090-2102

Zhu Y.; Paul P.; Lee S.; Craig B.T.; Rellinger E.J.; Qiao J.; Gius D.R.; Chung D.H. 09-01-2015. Antioxidant inhibition of steady-state reactive oxygen species and cell growth in neuroblastoma Surgery United States, 158 3, 827-836

Liang Q.; Benavides G.A.; Vassilopoulos A.; Gius D.; Darley-Usmar V.; Zhang J. 09-01-2013. Bioenergetic and autophagic control by Sirt3 in response to nutrient deprivation in mouse embryonic Biochemical Journal, 454 2, 249-257

Park S.H.; Ozden O.; Jiang H.; Cha Y.I.; Pennington J.D.; Aykin-Burns N.; Spitz D.R.; Gius D.; Kim H.S. 09-01-2011. Sirt3, mitochondrial ROS, ageing, and carcinogenesis International Journal of Molecular Sciences, 12 9, 6226-6239

Zhu Y.; Dean A.E.; Horikoshi N.; Heer C.; Spitz D.R.; Gius D. 08-31-2018. Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy Journal of Clinical Investigation, 128 9, 3682-3691

Baur J.A.; Chen D.; Chini E.N.; Chua K.; Cohen H.Y.; De Cabo R.; Deng C.; Dimmeler S.; Gius D.; Guarente L.P.; Helfand S.L.; Imai S.I.; Itoh H.; Kadowaki T.; Koya D.; Leeuwenburgh C.; Mcburney M.; Nabeshima Y.O.I.; Neri C.; Oberdoerffer P.; Pestell R.G.; Rogina B.; Sadoshima J.; Sartorelli V.; Serrano M.; Sinclair D.A.; Steegborn C.; Tatar M.; Tissenbaum H.A.; Tong Q.; Tsubota K.; Vaquero A.; Verdin E. 08-27-2010. Dietary restriction: Standing up for sirtuins Science, 329 5995, 1012-1013

Wei S.J.; Schell J.; Qian W.; Silguero M.; Baseviciene A.; Chen W.H.; Trevino R.; Chocron E.S.; Ogle M.M.; Varmazyad M.; Martinez G.M.; Cruz D.; Lorenzana B.; Dong F.F.; Jiang H.; Nazarullah A.; Beardsley R.A.; Sharma K.; Chang J.; Munkácsy E.; Horikoshi N.; Gius D. 08-26-2025. Divergent sex-specific effects on a ketogenic diet: Male, but not female, mice exhibit oxidative str Cell Reports, 44 8,

Zou X.; Santa-Maria C.A.; O'Brien J.; Gius D.; Zhu Y. 08-20-2016. Manganese Superoxide Dismutase Acetylation and Dysregulation, Due to Loss of SIRT3 Activity, Promote Antioxidants and Redox Signaling, 25 6, 326-336

Zhu Y.; Park S.H.; Ozden O.; Kim H.S.; Jiang H.; Vassilopoulos A.; Spitz D.R.; Gius D. 08-15-2012. Exploring the electrostatic repulsion model in the role of Sirt3 in directing MnSOD acetylation stat Free Radical Biology and Medicine, 53 4, 828-833

Trimble E.L.; Harlan L.C.; Gius D.; Stevens J.; Schwartz S.M. 08-15-2008. Patterns of care for women with cervical cancer in the United States Cancer, 113 4, 743-749

Zhang H.; Park S.H.; Pantazides B.G.; Karpiuk O.; Warren M.D.; Hardy C.W.; Duong D.M.; Park S.J.; Kim H.S.; Vassilopoulos A.; Seyfried N.T.; Johnsen S.A.; Gius D.; Yu D.S. 08-13-2013. SIRT2 directs the replication stress response through CDK9 deacetylation Proceedings of the National Academy of Sciences of the United States of America, 110 33, 13546-13551

Curry H.A.; Clemens R.A.; Shah S.; Bradbury C.M.; Botero A.; Goswami P.; Gius D. 08-13-1999. Heat shock inhibits radiation-induced activation of NF-?B via inhibition of I-?B kinase Journal of Biological Chemistry, 274 33, 23061-23067

Zou X.; Ratti B.A.; O’Brien J.G.; Lautenschlager S.O.; Gius D.R.; Bonini M.G.; Zhu Y. 08-01-2017. Manganese superoxide dismutase (SOD2): is there a center in the universe of mitochondrial redox sign Journal of Bioenergetics and Biomembranes, 49 4, 325-333

Zou X.; Zhu Y.; Park S.H.; Liu G.; O'Brien J.; Jiang H.; Gius D. 08-01-2017. SIRT3-mediated dimerization of IDH2 directs cancer cell metabolism and tumor growth Cancer Research, 77 15, 3990-3999

Vassilopoulos A.; Pennington J.D.; Andresson T.; Rees D.M.; Bosley A.D.; Fearnley I.M.; Ham A.; Flynn C.R.; Hill S.; Rose K.L.; Kim H.S.; Deng C.X.; Walker J.E.; Gius D. 08-01-2014. SIRT3 deacetylates ATP synthase F1 complex proteins in response to nutrient-and exercise-induced str Antioxidants and Redox Signaling, 21 4, 551-564

Jacobus J.A.; Duda C.G.; Coleman M.C.; Martin S.M.; Mapuskar K.; Mao G.; Smith B.J.; Aykin-Burns N.; Guida P.; Gius D.; Domann F.E.; Knudson C.M.; Spitz D.R. 08-01-2013. Low-dose radiation-induced enhancement of thymic lymphomagenesis in lck-bax mice is dependent on LET Radiation Research, 180 2, 156-165

Kassis J.N.; Virador V.M.; Guancial E.A.; Kimm D.; Ho A.S.; Mishra M.; Chuang E.Y.; Cook J.; Gius D.; Kohn E.C. 08-01-2009. Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3 - Modulated adhesion and Journal of Pathology, 218 4, 495-504

Gius D.; Funk M.C.; Chuang E.Y.; Feng S.; Huettner P.C.; Nguyen L.; Bradbury C.M.; Mishra M.; Gao S.; Buttin B.M.; Cohn D.E.; Powell M.A.; Horowitz N.S.; Whitcomb B.P.; Rader J. 08-01-2007. Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenes Cancer Research, 67 15, 7113-7123

Spitz D.; Azzam E.; Li J.; Gius D. 08-01-2004. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifying con Cancer and Metastasis Reviews, 23 3-4, 311-322

Ohiro Y.; Garkavtsev I.; Kobayashi S.; Sreekumar K.R.; Nantz R.; Higashikubo B.T.; Duffy S.L.; Higashikubo R.; Usheva A.; Gius D.; Kley N.; Horikoshi N. 07-31-2002. A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor ( FEBS Letters, 524 1-3, 163-171

Simone N.L.; Soule B.P.; Ly D.; Saleh A.D.; Savage J.E.; DeGraff W.; Cook J.; Harris C.C.; Gius D.; Mitchell J.B. 07-27-2009. Ionizing radiation-induced oxidative stress alters miRNA expression Plos One, 4 7,

Vidimar V.; Beilhartz G.L.; Park M.; Biancucci M.; Kieffer M.B.; Gius D.R.; Melnyk R.A.; Satchell K.J.F. 07-21-2020. An engineered chimeric toxin that cleaves activated mutant and wild-type RAS inhibits tumor growth Proceedings of the National Academy of Sciences of the United States of America, 117 29, 16938-16948

Traba J.; Geiger S.S.; Kwarteng-Siaw M.; Han K.; Ra O.H.; Siegel R.M.; Gius D.; Sack M.N. 07-21-2017. Prolonged fasting suppresses mitochondrial NLRP3 inflammasome assembly and activation via SIRT3-medi Journal of Biological Chemistry, 292 29, 12153-12164

Nguyen P.; Cui H.; Bisht K.S.; Sun L.; Patel K.; Lee R.S.; Kugoh H.; Oshimura M.; Feinberg A.P.; Gius D. 07-15-2008. CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the patern Cancer Research, 68 14, 5546-5551

Locke J.E.; Bradbury C.M.; Wei S.J.; Shah S.; Rene L.M.; Clemens R.A.; Roti J.R.; Horikoshi N.; Gius D. 07-04-2002. Indomethacin lowers the threshold thermal exposure for hyperthermic radiosensitization and heat-shoc International Journal of Radiation Biology, 78 6, 493-502

Cheresh P.; Kim S.J.; Jablonski R.; Watanabe S.; Lu Z.; Chi M.; Helmin K.A.; Gius D.; Scott Budinger G.R.; Kamp D.W. 07-01-2021. SIRT3 overexpression ameliorates asbestos-induced pulmonary fibrosis, mt-DNA damage and lung fibroge International Journal of Molecular Sciences, 22 13,

Park S.H.; Ozden O.; Liu G.; Song H.Y.; Zhu Y.; Yan Y.; Zou X.; Kang H.J.; Jiang H.; Principe D.R.; Cha Y.I.; Roh M.; Vassilopoulos A.; Gius D. 07-01-2016. SIRT2-mediated deacetylation and tetramerization of pyruvate kinase directs glycolysis and tumor gro Cancer Research, 76 13, 3802-3812

Gius D.; Spitz D.R. 07-01-2006. Redox signaling in cancer biology Antioxidants and Redox Signaling, 8 7-8, 1249-1252

Sekhar K.; Spitz D.; Harris S.; Nguyen T.; Meredith M.; Holt J.; Gius D.; Marnett L.; Summar M.; Freeman M. 07-01-2002. Erratum: Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced express Free Radical Biology and Medicine, 33 1, 149

Zhao W.; Chuang E.Y.; Mishra M.; Awwad R.; Bisht K.; Sun L.; Nguyen P.; Pennington J.D.; Wang T.J.C.; Bradbury C.M.; Huang L.; Chen Z.; Bar-Sela G.; Robbins M.E.C.; Gius D. 06-15-2006. Distinct effects of ionizing radiation on in vivo murine kidney and brain normal tissue gene express Clinical Cancer Research, 12 12, 3823-3830

Lin X.; Zhang F.; Bradbury C.M.; Kaushal A.; Li L.; Spitz D.R.; Aft R.L.; Gius D. 06-15-2003. 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disrupt Cancer Research, 63 12, 3413-3417

Diamond D.A.; Parsian A.; Hunt C.R.; Lofgren S.; Spitz D.R.; Goswami P.C.; Gius D. 06-11-1999. Redox factor-1 (Ref-1) mediates the activation of AP-1 in HeLa and NIH 3T3 cells in response to heat Journal of Biological Chemistry, 274 24, 16959-16964

Antic I.; Biancucci M.; Zhu Y.; Gius D.R.; Satchell K.J.F. 06-08-2015. Site-specific processing of Ras and Rap1 Switch i by a MARTX toxin effector domain Nature Communications, 6 ,

Vassilopoulos A.; Tominaga Y.; Kim H.S.; Lahusen T.; Li B.; Yu H.; Gius D.; Deng C.X. 06-04-2015. WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carc Oncogene, 34 23, 3023-3035

Zhou Z.; Song X.; Chi J.(.; Gius D.R.; Huang Y.; Cristofanilli M.; Wan Y. 06-01-2020. Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance Cellular Signalling, 70 ,

Jablonski R.P.; Kim S.J.; Cheresh P.; Williams D.B.; Morales-Nebreda L.; Cheng Y.; Yeldandi A.; Bhorade S.; Pardo A.; Selman M.; Ridge K.; Gius D.; Budinger G.R.S.; Kamp D.W. 06-01-2017. SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA dam FASEB Journal, 31 6, 2520-2532

Xu Y.; Gao X.D.; Lee J.H.; Huang H.; Tan H.; Ahn J.; Reinke L.M.; Peter M.E.; Feng Y.; Gius D.; Siziopikou K.P.; Peng J.; Xiao X.; Cheng C. 06-01-2014. Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative Genes and Development, 28 11, 1191-1203

Park S.H.; Zhu Y.; Ozden O.; Kim H.S.; Jiang H.; Deng C.X.; Gius D.; Vassilopoulos A. 06-01-2012. SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis Translational Cancer Research, 1 1, 15-21

Van Waes C.; Allen C.T.; Citrin D.; Gius D.; Colevas A.D.; Harold N.A.; Rudy S.; Nottingham L.; Muir C.; Chen Z.; Singh A.K.; Dancey J.; Morris J.C. 06-01-2010. Molecular and Clinical Responses in a Pilot Study of Gefitinib With Paclitaxel and Radiation in Loca International Journal of Radiation Oncology Biology Physics, 77 2, 447-454

Gius D.; Botero A.; Shah S.; Curry H.A. 06-01-1999. Intracellular oxidation/reduction status in the regulation of transcription factors NF-?B and AP-1 Toxicology Letters, 106 2-3, 93-106

Gius D.R.; Ezhevsky S.A.; Becker-Hapak M.; Nagahara H.; Wei M.C.; Dowdy S.F. 06-01-1999. Transduced p16(INK4a) peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cy Cancer Research, 59 11, 2577-2580

Liu G.; Park S.H.; Imbesi M.; Nathan W.J.; Zou X.; Zhu Y.; Jiang H.; Parisiadou L.; Gius D. 05-20-2017. Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dys Antioxidants and Redox Signaling, 26 15, 846-863

Nguyen P.; Awwad R.T.; Smart D.D.K.; Spitz D.R.; Gius D. 05-18-2006. Thioredoxin reductase as a novel molecular target for cancer therapy Cancer Letters, 236 2, 164-174

Wei S.J.; Schell J.R.; Chocron E.S.; Varmazyad M.; Xu G.; Chen W.H.; Martinez G.M.; Dong F.F.; Sreenivas P.; Trevino R.; Jiang H.; Du Y.; Saliba A.; Qian W.; Lorenzana B.; Nazarullah A.; Chang J.; Sharma K.; Munkácsy E.; Horikoshi N.; Gius D. 05-17-2024. Ketogenic diet induces p53-dependent cellular senescence in multiple organs Science Advances, 10 20,

Xu G.; Quan S.; Schell J.; Gao Y.; Varmazyad M.; Sreenivas P.; Cruz D.; Jiang H.; Pan M.; Han X.; Palavicini J.P.; Zhao P.; Sun X.; Marchant E.D.; Rasmussen B.B.; Li G.; Katsumura S.; Morita M.; Munkácsy E.; Horikoshi N.; Sandra Chocron E.; Gius D. 05-17-2024. Mitochondrial ACSS1-K635 acetylation knock-in mice exhibit altered metabolism, cell senescence, and Science Advances, 10 20,

Shi H.; Deng H.X.; Gius D.; Schumacker P.T.; Surmeier D.J.; Ma Y.C. 05-15-2017. Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress Human Molecular Genetics, 26 10, 1915-1926

Haigis M.C.; Deng C.X.; Finley L.W.S.; Kim H.S.; Gius D. 05-15-2012. SIRT3 is a mitochondrial tumor suppressor: A scientific tale that connects aberrant cellular ROS, th Cancer Research, 72 10, 2468-2472

Xu G.; Schell J.; Quan S.; Gao Y.; Wei S.J.; Pan M.; Han X.; Li G.; Zhou D.; Jiang H.; Dong F.F.; Munkácsy E.; Horikoshi N.; Gius D. 05-01-2025. Mitochondrial ACSS1-K635 acetylation knock-in mice exhibit altered liver lipid metabolism on a ketog Free Radical Biology and Medicine, 232 , 260-268

Wang X.X.; Edelstein M.H.; Gafter U.; Qiu L.; Luo Y.; Dobrinskikh E.; Lucia S.; Adorini L.; D'Agati V.D.; Levi J.; Rosenberg A.; Kopp J.B.; Gius D.R.; Saleem M.A.; Levi M. 05-01-2016. G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes Journal of the American Society of Nephrology, 27 5, 1362-1378

Bao J.; Lu Z.; Joseph J.J.; Carabenciov D.; Dimond C.C.; Pang L.; Samsel L.; McCoy J.P.; Leclerc J.; Nguyen P.M.; Gius D.; Sack M.N. 05-01-2010. Characterization of the murine SIRT3 mitochondrial localization sequence and comparison of mitochond Journal of Cellular Biochemistry, 110 1, 238-247

Barker C.; Burgan W.; Carter D.; Cerna D.; Gius D.; Hollingshead M.; Camphausen K.; Tofilon P. 05-01-2006. In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor triapine ( Clinical Cancer Research, 12 9, 2912-2918

Vassilopoulos A.; Wang R.H.; Gius D. 04-25-2018. Mammalian Sirtuins, Cellular Energy Regulation, and Metabolism, and Carcinogenesis Introductory Review on Sirtuins in Biology Aging and Disease, , 141-154

Sun L.; Huang L.; Nguyen P.; Bisht K.S.; Bar-Sela G.; Ho A.S.; Bradbury C.M.; Yu W.; Cui H.; Lee S.; Trepel J.B.; Feinberg A.P.; Gius D. 04-15-2008. DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulati Cancer Research, 68 8, 2726-2735

Bradbury C.M.; Locke J.E.; Wei S.J.; Rene L.M.; Karimpour S.; Hunt C.; Spitz D.R.; Gius D. 04-15-2001. Increased activator protein 1 activity as well as resistance to heat-induced radiosensitization, hyd Cancer Research, 61 8, 3486-3492

Pillai V.B.; Samant S.; Sundaresan N.R.; Raghuraman H.; Kim G.; Bonner M.Y.; Arbiser J.L.; Walker D.I.; Jones D.P.; Gius D.; Gupta M.P. 04-14-2015. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3 Nature Communications, 6 ,

Wang J.; Anderson P.D.; Luo W.; Gius D.; Roh M.; Abdulkadir S.A. 04-05-2012. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells Oncogene, 31 14, 1794-1803

Yang X.; Park S.H.; Chang H.C.; Shapiro J.S.; Vassilopoulos A.; Sawicki K.T.; Chen C.; Shang M.; Burridge P.W.; Epting C.L.; Wilsbacher L.D.; Jenkitkasemwong S.; Knutson M.; Gius D.; Ardehali H. 04-03-2017. Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2 Journal of Clinical Investigation, 127 4, 1505-1516

Ogle M.M.; Trevino R.; Schell J.; Varmazyad M.; Horikoshi N.; Gius D. 04-01-2022. Manganese Superoxide Dismutase Acetylation and Regulation of Protein Structure in Breast Cancer Biol Antioxidants, 11 4,

Zhu Y.; Gius D. 04-01-2018. Glycogen phosphorylase: A novel biomarker in doxorubicin-induced cardiac injury Clinical Cancer Research, 24 7, 1516-1517

Tao R.; Vassilopoulos A.; Parisiadou L.; Yan Y.; Gius D. 04-01-2014. Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling netwo Antioxidants and Redox Signaling, 20 10, 1646-1654

Wang T.; Hui Y.C.; Dong S.; Fan M.; Tamae D.; Ozeki M.; Gao Q.; Gius D.; Jian J.L. 04-01-2005. Co-activation of ERK, NF-??, and GADD45? in response to ionizing radiation Journal of Biological Chemistry, 280 13, 12593-12601

Sekhar K.R.; Spitz D.R.; Harris S.; Nguyen T.T.; Meredith M.J.; Holt J.T.; Guis D.; Marnett L.J.; Summar M.L.; Freeman M.L. 04-01-2002. Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of ?- Free Radical Biology and Medicine, 32 7, 650-662

Coleman M.C.; Olivier A.K.; Jacobus J.A.; Mapuskar K.A.; Mao G.; Martin S.M.; Riley D.P.; Gius D.; Spitz D.R. 03-20-2014. Superoxide mediates acute liver injury in irradiated mice lacking Sirtuin 3 Antioxidants and Redox Signaling, 20 9, 1423-1435

Hallahan D.E.; Gius D.; Kuchibhotla J.; Sukhatme V.; Kufe D.W.; Weichselbaum R.R. 03-05-1993. Radiation signaling mediated by jun activation following dissociation from a cell type-specific repr Journal of Biological Chemistry, 268 7, 4903-4907

Schell J.R.; Wei S.J.; Zhang J.; Trevino R.; Chen W.H.; Aguilar L.; Qian W.; Corbett C.W.; Jiang H.; Dong F.F.; Chocron E.S.; Nazarullah A.; Chang J.; Flanagan M.E.; Glatt V.; Dikalov S.; Munkácsy E.; Horikoshi N.; Gius D. 03-01-2025. MnSOD non-acetylation mimic knock-in mice exhibit dilated cardiomyopathy Free Radical Biology and Medicine, 229 , 58-67

Gius D.; Mattson D.; Bradbury C.M.; Smart D.K.; Spitz D.R. 03-01-2004. Thermal stress and the disruption of redox-sensitive signalling and transcription factor activation: International Journal of Hyperthermia, 20 2, 213-223

Nottingham L.K.; Yan C.H.; Yang X.; Si H.; Coupar J.; Bian Y.; Cheng T.F.; Allen C.; Arun P.; Gius D.; Dang L.; Van Waes C.; Chen Z. 02-27-2014. Aberrant IKK? and IKK? cooperatively activate NF-?B and induce EGFR/AP1 signaling to promote surviva Oncogene, 33 9, 1135-1147

Zhang H.; Head P.S.E.; Daddacha W.; Park S.H.; Li X.; Pan Y.; Madden M.Z.; Duong D.M.; Xie M.; Yu B.; Warren M.D.; Liu E.A.; Dhere V.R.; Li C.; Pradilla I.; Torres M.A.; Wang Y.; Dynan W.S.; Doetsch P.W.; Deng X.; Seyfried N.T.; Gius D.; Yu D.S. 02-16-2016. ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA Cell Reports, 14 6, 1435-1447

Zhang S.; Weinberg S.; DeBerge M.; Gainullina A.; Schipma M.; Kinchen J.M.; Ben-Sahra I.; Gius D.R.; Yvan-Charvet L.; Chandel N.S.; Schumacker P.T.; Thorp E.B. 02-05-2019. Efferocytosis Fuels Requirements of Fatty Acid Oxidation and the Electron Transport Chain to Polariz Cell Metabolism, 29 2, 443-456.e5

Song H.Y.; Rellinger E.J.; Park S.H.; Paul P.; Qiao J.; Vasilopoulos A.; Ozden O.; Gius D.; Chung D.H. 02-01-2018. Inhibition of sirtuin 6 induces neuroblastoma differentiation Anticancer Research, 38 2, 647-654

Kendrick A.A.; Choudhury M.; Rahman S.M.; McCurdy C.E.; Friederich M.; Van Hove J.L.K.; Watson P.A.; Birdsey N.; Bao J.; Gius D.; Sack M.N.; Jing E.; Kahn C.R.; Friedman J.E.; Jonscher K.R. 02-01-2011. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation Biochemical Journal, 433 3, 505-514

Mishra M.V.; Bisht K.S.; Sun L.; Muldoon-Jacobs K.; Awwad R.; Kaushal A.; Nguyen P.; Huang L.; Pennington J.D.; Markovina S.; Bradbury C.M.; Gius D. 02-01-2008. DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells Molecular Cancer Research, 6 2, 243-249

Zoberi I.; Bradbury C.M.; Curry H.A.; Bisht K.S.; Goswami P.C.; Roti Roti J.L.; Gius D. 01-25-2002. Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell line Cancer Letters, 175 2, 165-173

Lagunas L.; Bradbury C.; Laszlo A.; Hunt C.; Gius D. 01-23-2004. Indomethacin and ibuprofen induce Hsc70 nuclear localization and activation of the heat shock respon Biochemical and Biophysical Research Communications, 313 4, 863-870

Kim H.S.; Patel K.; Muldoon-Jacobs K.; Bisht K.S.; Aykin-Burns N.; Pennington J.D.; van der Meer R.; Nguyen P.; Savage J.; Owens K.M.; Vassilopoulos A.; Ozden O.; Park S.H.; Singh K.K.; Abdulkadir S.A.; Spitz D.R.; Deng C.X.; Gius D. 01-19-2010. SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integri Cancer Cell, 17 1, 41-52

Kosciuczuk E.M.; Mehrotra S.; Saleiro D.; Kroczynska B.; Majchrzak-Kita B.; Lisowski P.; Driehaus C.; Rogalska A.; Turner A.; Lienhoop T.; Gius D.; Fish E.N.; Vassilopoulos A.; Platanias L.C. 01-18-2019. Sirtuin 2–mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I int Journal of Biological Chemistry, 294 3, 827-837

Scarbrough P.M.; Mapuskar K.A.; Mattson D.M.; Gius D.; Watson W.H.; Spitz D.R. 01-15-2012. Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potenti Free Radical Biology and Medicine, 52 2, 436-443

Chocron S.S.; Zhang D.; Sumawi B.; Schell J.; Cruz D.; Li G.; Sreenivas P.; Jiang H.; Dong F.F.; Munkácsy E.; Zhao S.; Porras M.A.G.; Gius D. 01-01-2026. ?3-adrenergic receptor agonist causes acute thermogenic metabolic crisis in ACSS1-K635Q knock-in mic International Journal of Biological Sciences, 22 3, 1070-1081

Khan M.A.; Koniyan S.; Ahir M.; Jegga A.G.; Mayes M.D.; Gius D.; Leung J.; Bonnen M.D.; Montesi S.B.; Ghebre Y.T. 01-01-2026. Esomeprazole inhibits proliferation of scleroderma fibroblasts via cell cycle regulation Frontiers in Pharmacology, 16 ,

Gao Y.; Zhu Y.; Tran E.L.; Tokars V.; Dean A.E.; Quan S.; Gius D. 01-01-2021. Mnsod lysine 68 acetylation leads to cisplatin and doxorubicin resistance due to aberrant mitochondr International Journal of Biological Sciences, 17 5, 1203-1216

Gius D.; Zhu Y. 01-01-2019. Homeostatic roles of STING in cell proliferation and chromosomal instability Cancer Research, 79 7, 1295-1296

He C.; Danes J.M.; Hart P.C.; Zhu Y.; Huang Y.; de Abreu A.L.; O’Brien J.; Mathison A.J.; Tang B.; Frasor J.M.; Wakefield L.M.; Ganini D.; Stauder E.; Zielonka J.; Gantner B.N.; Urrutia R.A.; Gius D.; Bonini M.G. 01-01-2019. SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer Proceedings of the National Academy of Sciences of the United States of America, 116 47, 23534-23541

Song H.Y.; Biancucci M.; Kang H.J.; O'Callaghan C.; Park S.H.; Principe D.R.; Jiang H.; Yan Y.; Satchell K.F.; Raparia K.; Gius D.; Vassilopoulos A. 01-01-2016. SIRT2 deletion enhances KRAS-induced tumorigenesis in vivo by regulating K147 acetylation status Oncotarget, 7 49, 80336-80349

Agarwal S.; Zhu Y.; Gius D.R.; Satchell K.J.F. 01-01-2015. The Makes Caterpillars Floppy (MCF)-like domain of Vibrio vulnificus induces mitochondrion-mediated Infection and Immunity, 83 11, 4392-4403

Tao R.; Leclerc J.; Yildiz K.; Park S.H.; Jung B.; Gius D.; Özden Ö. 01-01-2015. Changes in gene expression in SIRT3 knockout liver cells Turkish Journal of Biology, 39 3, 380-387

Chi A.; Nguyen N.P.; Welsh J.S.; Tse W.; Monga M.; Oduntan O.; Almubarak M.; Rogers J.; Remick S.C.; Gius D. 01-01-2014. Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: Image Frontiers in Oncology, 4 JUN ,

Desouki M.M.; Doubinskaia I.; Gius D.; Abdulkadir S.A. 01-01-2014. Decreased mitochondrial SIRT3 expression is a potential molecular biomarker associated with poor out Human Pathology, 45 5, 1071-1077

Ozden O.; Park S.H.; Wagner B.A.; Song H.Y.; Zhu Y.; Vassilopoulos A.; Jung B.; Buettner G.R.; Gius D. 01-01-2014. SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells Free Radical Biology and Medicine, 76 , 163-172

Peek C.B.; Affinati A.H.; Ramsey K.M.; Kuo H.Y.; Yu W.; Sena L.A.; Ilkayeva O.; Marcheva B.; Kobayashi Y.; Omura C.; Levine D.C.; Bacsik D.J.; Gius D.; Newgard C.B.; Goetzman E.; Chandel N.S.; Denu J.M.; Mrksich M.; Bass J. 01-01-2013. Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice Science, 342 6158,

Shankavaram U.; Fliedner S.; Elkahloun A.; Barb J.; Munson P.; Huynh T.; Matro J.; Turkova H.; Marston Linehan W.; Timmers H.; Tischler A.; Powers J.; de Krijger R.; Baysal B.; Takacova M.; Pastorekova S.; Gius D.; Lehnert H.; Camphausen K.; Pacak K. 01-01-2013. Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragan Neoplasia United States, 15 4, 435-447

Spitz D.R.; Dornfeld K.J.; Krishnan K.; Gius D. 01-01-2012. Oxidative stress in cancer biology and therapy Oxidative Stress in Cancer Biology and Therapy, , 1-460

Kamrava M.; Gius D.; Casagrande G.; Kohn E. 01-01-2011. Will targeting insulin growth factor help us or hurt us?: An oncologist's perspective Ageing Research Reviews, 10 1, 62-70

Kim H.S.; Vassilopoulos A.; Wang R.H.; Lahusen T.; Xiao Z.; Xu X.; Li C.; Veenstra T.D.; Li B.; Yu H.; Ji J.; Wang X.W.; Park S.H.; Cha Y.I.; Gius D.; Deng C.X. 01-01-2011. SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity Cancer Cell, 20 4, 487-499

Ozden O.; Park S.H.; Kim H.S.; Jiang H.; Coleman M.C.; Spitz D.R.; Gius D. 01-01-2011. Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative Aging, 3 2, 102-107

Vassilopoulos A.; Fritz K.S.; Petersen D.R.; Gius D. 01-01-2011. The human sirtuin family: Evolutionary divergences and functions Human Genomics, 5 5, 485-496

Guo Z.; Tsai M.H.; Shiao Y.H.; Chen L.H.; Wei M.L.; Lv X.; Gius D.; Little J.B.; Mitchell J.B.; Chuang E.Y. 01-01-2008. DNA (cytosine-5)-methyltransferase 1 as a mediator of mutant p53-determined p16ink4A down-regulation Journal of Biomedical Science, 15 2, 163-168

Yu W.; Gius D.; Onyango P.; Muldoon-Jacobs K.; Karp J.; Feinberg A.P.; Cui H. 01-01-2008. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA Nature, 451 7175, 202-206

Bar-Sela G.; Jacobs K.M.; Gius D. 01-01-2007. Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation respons Cancer Journal, 13 1, 65-69

Pennington J.D.; Jacobs K.M.; Sun L.; Bar-Sela G.; Mishra M.; Gius D. 01-01-2007. Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy Current Pharmaceutical Design, 13 33, 3368-3377

Pennington J.; Wang T.; Nguyen P.; Sun L.; Bisht K.; Smart D.; Gius D. 01-01-2005. Redox-sensitive signaling factors as a novel molecular targets for cancer therapy Drug Resistance Updates, 8 5, 322-330

Cook J.A.; Gius D.; Wink D.A.; Krishna M.C.; Russo A.; Mitchell J.B. 01-01-2004. Oxidative stress, redox, and the tumor microenvironment Seminars in Radiation Oncology, 14 3, 259-266

Gius D. 01-01-2004. Redox-sensitive signaling factors and antioxidants: How tumor cells respond to ionizing radiation Journal of Nutrition, 134 11,

Gius D.; Cui H.; Bradbury C.M.; Cook J.; Smart D.D.K.; Zhao S.; Young L.; Brandenburg S.A.; Hu Y.; Bisht K.S.; Ho A.S.; Mattson D.; Sun L.; Munson P.J.; Chuang E.Y.; Mitchell J.B.; Feinberg A.P. 01-01-2004. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome rev Cancer Cell, 6 4, 361-371

Mattson D.; Bradbury C.M.; Bisht K.S.; Curry H.A.; Spitz D.R.; Gius D. 01-01-2004. Heat shock and the activation of AP-1 and inhibition of NF-?B DNA-binding activity: Possible role of International Journal of Hyperthermia, 20 2, 224-233

Mimnaugh E.G.; Xu W.; Vos M.; Yuan X.; Isaacs J.S.; Bisht K.S.; Gius D.; Neckers L. 01-01-2004. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endopla Molecular Cancer Therapeutics, 3 5, 551-566

Karimpour S.; Gius D. 01-01-2003. The holy grail of radiation oncology: Lessons learned from hyperthermia International Journal of Radiation Oncology Biology Physics, 55 1, 3-4

Ohiro Y.; Usheva A.; Kobayashi S.; Duffy S.; Nantz R.; Gius D.; Horikoshi N. 01-01-2003. Inhibition of stress-inducible kinase pathways by tumorigenic mutant p53 Molecular and Cellular Biology, 23 1, 322-334

Trimble E.; Schoenfeldt M.; Streicher H.; Gius D.; Cornelison T. 01-01-2003. Clinical Trials Referral Resource. Clinical trials in cervical cancer. Oncology Williston Park N Y, 17 1, 84-89

Aft R.L.; Zhang F.W.; Gius D. 01-01-2002. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: Mechanism of cell death British Journal of Cancer, 87 7, 805-812

Karimpour S.; Lou J.; Lin L.L.; Rene L.M.; Lagunas L.; Ma X.; Karra S.; Bradbury C.M.; Markovina S.; Goswami P.C.; Spitz D.R.; Hirota K.; Kalvakolanu D.V.; Yodoi J.; Gius D. 01-01-2002. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active Oncogene, 21 41, 6317-6327

Rim M.; Qureshi S.A.; Gius D.; Nho J.; Sukhatme V.P.; Foster D.A. 01-01-1992. Evidence that activation of the Egr-1 promoter by v-Raf involves serum response elements Oncogene, 7 10, 2069-2072

Gius D.; Cao X.; Rauscher F.; Cohen D.; Curran T.; Sukhatme V. 01-01-1990. Transcriptional activation and repression by fos are independent functions: The C terminus represses Molecular and Cellular Biology, 10 8, 4243-4255

Gius D.; Laimins L.A. 01-01-1989. Activation of human papillomavirus type 18 gene expression by herpes simplex virus type 1 viral tran Journal of Virology, 63 2, 555-563

Gius D.; Grossman S.; Bedell M.A.; Laimins L.A. 01-01-1988. Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18 Journal of Virology, 62 3, 665-672